Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Not applicableLooking for participantsNCT03685045
What this trial is testing

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

Who this might be right for
Hepatitis C
Kirby Institute 6,000
Testing effectiveness (Phase 2)UnknownNCT03067883
What this trial is testing

Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients

Who this might be right for
Chronic Hepatitis c
Ain Shams University 40
Not applicableStudy completedNCT04113629
What this trial is testing

Simplified Monitoring Myanmar SM2 Study

Who this might be right for
Hepatitis CLiver CirrhosesLiver Inflammation+1 more
Kirby Institute 200
Early research (Phase 1)Study completedNCT01094873
What this trial is testing

Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

Who this might be right for
Hepatitis C
ReiThera Srl 35
Early research (Phase 1)Study completedNCT00906256
What this trial is testing

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

Who this might be right for
Healthy
Arrow Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT01707472
What this trial is testing

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Who this might be right for
Liver FibrosisHepatitis CHIV+1 more
Gilead Sciences 18
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Large-scale testing (Phase 3)Study completedNCT02032875
What this trial is testing

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 116
Testing effectiveness (Phase 2)Study completedNCT01580995
What this trial is testing

Herpes Simplex Type 1 Suppression in Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 19
Testing effectiveness (Phase 2)Ended earlyNCT01440595
What this trial is testing

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 5
Large-scale testing (Phase 3)Study completedNCT01276756
What this trial is testing

Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis c
Cairo University 100
Early research (Phase 1)Study completedNCT00718172
What this trial is testing

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 81
Large-scale testing (Phase 3)Study completedNCT02806505
What this trial is testing

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 81
Early research (Phase 1)Study completedNCT00903773
What this trial is testing

VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.

Who this might be right for
Hepatitis CKidney Diseases
Tibotec BVBA 24
Testing effectiveness (Phase 2)Study completedNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Post-approval studies (Phase 4)WithdrawnNCT01415141
What this trial is testing

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Who this might be right for
Hepatitis C
University of Vermont
Early research (Phase 1)Study completedNCT01458054
What this trial is testing

Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults

Who this might be right for
Hepatitis C
GlaxoSmithKline 28
Not applicableLooking for participantsNCT05042544
What this trial is testing

The Australian HCV Point-of-Care Testing Program

Who this might be right for
Hepatitis C
Kirby Institute 60,000
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation